CDKN2A and acute lymphoblastic leukemia: The aim of this study was to discuss the occurrence and clinical characteristics of CDKN2A/B deletion in pediatric ALL patients, explore whether CDKN2A/B deletion is related to the prognosis of pediatric ALL patients, and provide a new insight for the clinical treatment and prognostic assessment of pediatric ALL patients.